Inhibitory effect of bortezomib on human multiple myeloma cells when combined with epigallocatechin-gallate (EGCG) analogs
Abstract
EGCG analogs 6 and 8 with
* Corresponding authors
a
Department of Chemistry, McGill University, Montreal, Quebec, Canada
E-mail:
tak-hang.chan@mcgill.ca
b
Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, USA
E-mail:
doup@karmanos.org
c
Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong
E-mail:
bcchanth@polyu.edu.hk
EGCG analogs 6 and 8 with
S. Pamu, D. Chen, F. Morin, C. Huo, Q. Cui, Q. P. Dou and T. H. Chan, Med. Chem. Commun., 2012, 3, 229 DOI: 10.1039/C1MD00260K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content